Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease.Published in:EMBO Molecular Medicine, 2010, v. 2, n. 9, p. 349, doi. 10.1002/emmm.201000084By:McConoughey, Stephen J.;Basso, Manuela;Niatsetskaya, Zoya V.;Sleiman, Sama F.;Smirnova, Natalia A.;Langley, Brett C.;Mahishi, Lata;Cooper, Arthur J. L.;Antonyak, Marc A.;Cerione, Rick A.;Li, Bo;Starkov, Anatoly;Chaturvedi, Rajnish Kumar;Beal, M. Flint;Coppola, Giovanni;Geschwind, Daniel H.;Ryu, Hoon;Xia, Li;Iismaa, Siiri E.;Pallos, JuditPublication type:Article